273 related articles for article (PubMed ID: 27550404)
1. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).
Cha J; Kim YS; Park W; Kim HJ; Kim JY; Kim JH; Kim J; Yoon WS; Kim JW; Kim YB
J Gynecol Oncol; 2016 Nov; 27(6):e58. PubMed ID: 27550404
[TBL] [Abstract][Full Text] [Related]
2. Vaginal brachytherapy for early-stage carcinosarcoma of the uterus.
Brown LC; Petersen IA; Haddock MG; Bakkum-Gamez JN; Lee LJ; Cimbak NC; Berkowitz RS; Viswanathan AN
Brachytherapy; 2015; 14(4):433-9. PubMed ID: 25890795
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Adjuvant Pelvic Radiotherapy on Distant Metastasis for Uterine Carcinosarcoma.
Eng NL; Rana SR; Hall KL; Eng TY
Am J Clin Oncol; 2021 Apr; 44(4):169-173. PubMed ID: 33481373
[TBL] [Abstract][Full Text] [Related]
5. Impact of adjuvant pelvic radiotherapy in stage I uterine sarcoma.
Magnuson WJ; Petereit DG; Anderson BM; Geye HM; Bradley KA
Anticancer Res; 2015 Jan; 35(1):365-70. PubMed ID: 25550573
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma.
Patel N; Hegarty SE; Cantrell LA; Mishra MV; Showalter TN
Brachytherapy; 2015; 14(5):606-12. PubMed ID: 26166579
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy for uterine carcinosarcoma: A retrospective assessment of treatment outcomes.
Yilmaz U; Alanyali S; Aras AB; Ozsaran Z
J Cancer Res Ther; 2019; 15(6):1377-1382. PubMed ID: 31898676
[TBL] [Abstract][Full Text] [Related]
10. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
Nemani D; Mitra N; Guo M; Lin L
Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.
Makker V; Kravetz SJ; Gallagher J; Orodel OP; Zhou Q; Iasonos A; DeLair D; Aghajanian C; Hensley ML
Int J Gynecol Cancer; 2013 Nov; 23(9):1635-41. PubMed ID: 24172099
[TBL] [Abstract][Full Text] [Related]
13. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
Le T
Eur J Surg Oncol; 2001 Apr; 27(3):282-5. PubMed ID: 11373106
[TBL] [Abstract][Full Text] [Related]
15. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study.
Li Y; Ren H; Wang J
BMC Cancer; 2019 Jul; 19(1):697. PubMed ID: 31307426
[TBL] [Abstract][Full Text] [Related]
16. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy.
Seagle BL; Kanis M; Kocherginsky M; Strauss JB; Shahabi S
Gynecol Oncol; 2017 Apr; 145(1):71-77. PubMed ID: 28317560
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
Sorbe B; Johansson B
Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
[TBL] [Abstract][Full Text] [Related]
18. Early-stage carcinosarcoma of the uterus: the significance of lymph node count.
Temkin SM; Hellmann M; Lee YC; Abulafia O
Int J Gynecol Cancer; 2007; 17(1):215-9. PubMed ID: 17291256
[TBL] [Abstract][Full Text] [Related]
19. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.
Stokes WA; Jones BL; Schefter TE; Fisher CM
Brachytherapy; 2018; 17(1):194-200. PubMed ID: 29097136
[TBL] [Abstract][Full Text] [Related]
20. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
